Autologous Adipose-Derived Mesenchymal Stromal Cells

DRUG3 trials

Sponsors

Jacob L. Sellon, M.D., Mayo Clinic

Conditions

ALSAmyotrophic Lateral SclerosisDegenerative Disc DiseaseOsteoarthritis, Knee

Phase 1

Autologous Culture Expanded Mesenchymal Stromal Cells for Knee Osteoarthritis

CompletedNCT02805855

Jacob L. Sellon, M.D.Osteoarthritis, Knee

Start: 2016-10-26End: 2023-09-28Updated: 2023-12-11

Autologous, Culture-Expanded Mesenchymal Stromal Cells for Degenerative Disc Disease

TerminatedNCT03461458

Mayo ClinicDegenerative Disc Disease

Start: 2018-10-17End: 2021-02-06Updated: 2022-01-25

Phase 2

Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS)

Active, not recruitingNCT03268603

Mayo ClinicALS, Amyotrophic Lateral Sclerosis

Start: 2017-10-10End: 2026-12-31Updated: 2026-03-09

Related Papers

Autologous cultured adipose derived mesenchymal stem cells combined with hyaluronic acid hydrogel in the treatment of discogenic low back pain: a study protocol for a phase II randomised controlled trial

BMJ Open2022-10-017 citations